7 Hrs
Source:
هبة بريس
Reducing drug profits: reform or market test
Amid the transformations taking place in the healthcare sector, the discussion surrounding drug prices is now focused on achieving a balance between protecting citizens' purchasing power and ensuring the sustainability of the pharmaceutical system. The decision to reduce profit margins on medicines, especially those priced above 300 dirhams, aims to lower costs for consumers while maintaining the sustainability of the pharmaceutical market.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)